70
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection

, , , , , , , & show all
Pages 7345-7352 | Published online: 05 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tianbao Liao, Tingting Su, Lina Huang, Bixun Li & Lu-Huai Feng. (2022) Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms. Scandinavian Journal of Gastroenterology 57:1, pages 85-90.
Read now
Lili Lu, Yuru Shang, Christina Susanne Mullins, Xianbin Zhang & Michael Linnebacher. (2021) Epidemiologic Trends and Prognostic Risk Factors of Patients with Pancreatic Neuroendocrine Neoplasms in the US: an Updated Population-Based Study. Future Oncology 17:5, pages 549-563.
Read now
Jin-Song Cai, Hai-Yan Chen, Yuan-Fei Lu & Ri-Sheng Yu. (2020) A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study. Future Oncology 16:2, pages 4369-4379.
Read now

Articles from other publishers (9)

Xun Li, Lin Chen & Junli Li. (2023) Comparing the predictive performance of different lymph node staging systems for postoperative overall survival in patients with ampullary carcinoma. Frontiers in Surgery 10.
Crossref
E. Merola, A. Pascher, A. Rinke, D. K. Bartsch, A. Zerbi, G. Nappo, C. Carnaghi, M. Ciola, M. G. McNamara, W. Zandee, E. Bertani, S. Marcucci, R. Modica, R. Grützmann, N. Fazio, W. de Herder, J. W. Valle, T. M. Gress, G. Delle Fave, G. de Pretis, A. Perren, B. Wiedenmann & M. E. Pavel. (2022) Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence. Annals of Surgical Oncology 29:9, pages 5568-5577.
Crossref
Jie Jian, Yuan Nie, Chenkai Huang, Sizhe Wan & Xuan Zhu. (2022) A scoring model predicting overall survival for hepatocellular carcinoma patients who receive surgery and chemotherapy. Indian Journal of Surgery 84:S2, pages 365-372.
Crossref
Jingxiang Shi, Sifan Liu, Jisen Cao, Shigang Shan, Chaoyi Ren, Jinjuan Zhang & Yijun Wang. (2022) Prognostic Nomogram Based on the Metastatic Lymph Node Ratio for T1-4N0-1M0 Pancreatic Neuroendocrine Tumors After Surgery. Frontiers in Oncology 12.
Crossref
Xiao Lei, Luo Qingqing, Yuan Weijie, Peng Li, Changhao Huang, Yu Kexun & Chen Zihua. (2022) Effect of surgical treatment for anorectal melanoma: a propensity score-matched analysis of the Surveillance, Epidemiology, and End Results programme data. BMJ Open 12:4, pages e053339.
Crossref
Zuoli Song, Sumei Wang, Yujing Wu, Jinjuan Zhang & Shuye Liu. (2021) Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival of Patients With Pancreatic Neuroendocrine Tumors. Pancreas 50:3, pages 414-422.
Crossref
Stefano Partelli, Luca Landoni, Valentina Andreasi, Chiara Nessi, Francesca Muffatti, Stefano Crippa, Sara Cingarlini, Claudio Bassi & Massimo Falconi. (2020) Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors. Surgery 168:5, pages 816-824.
Crossref
Sonja Levy, Linde M. van Veenendaal, Catharina M. Korse, Emilie C.H. Breekveldt, Wieke H.M. Verbeek, Menno R. Vriens, Koert F.D. Kuhlmann, José G. van den Berg, Gerlof D. Valk & Margot E.T. Tesselaar. (2020) Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival. Journal of Clinical Medicine 9:8, pages 2502.
Crossref
Teresa Starzyńska, Jakub Karczmarski, Agnieszka Paziewska, Maria Kulecka, Katarzyna Kuśnierz, Natalia Żeber-Lubecka, Filip Ambrożkiewicz, Michał Mikula, Beata Kos-Kudła & Jerzy Ostrowski. (2020) Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling. International Journal of Molecular Sciences 21:12, pages 4470.
Crossref